An incomplete step in the right direction: Peru’s National Institute of Health establishes cost-effectiveness threshold

Ministerio de Salud (PE). Resolución Ministerial N° 159-2022/MINSA, de 4 de marzo de 2022. Establecer el umbral de costo - efectividad de las evaluaciones de tecnologías sanitarias realizadas por la Dirección General de Medicamentos, Insumos y Drogas y por el Instituto Nacional de Salud. Lima (PE); 2022.

Ministerio de Economia y Finanzas (PE). Decreto Supremo Nº 398-2021EF, de 30 de diciembre de 2021. Valor de la Unidad Impositiva Tributaria durante el año 2022. (Lima (PE); 2021.

Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016;19(8):929-35. https://doi.org/10.1016/j.jval.2016.02.017

Revill P, Walker S, Madan J, Ciaranello A, Mwase T, Gibb DM, Claxton K, et al. Using cost-effectiveness thresholds to determine value for money in low-and middle-income country healthcare systems: are current international norms fit for purpose? York (UK): Centre for Health Economics, University of York; 2014. (Working Paper. CHE Research paper).

Kazibwe J, Gheorge A, Wilson D, Ruiz F, Chalkidou K, Chi YL. The use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review. Value Health. 2022;25(3):385-9. https://doi.org/10.1016/j.jval.2021.08.014

Augustovski F, Garay OU, Pichon-Riviere A, Rubinstein A, Caporale JE. Economic evaluation guidelines in Latin America: a current snapshot. Expert Rev Pharmacoecon Outcomes Res. 2010;10(5):525-37. https://doi.org/10.1586/erp.10.56

Thokala P, Ochalek J, Leech AA, Tong T. Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics. 2018;36(5):509-22. https://doi.org/10.1007/s40273-017-0606-1